(Q73915268)

English

A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study)

scientific article published on 01 July 2000

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

H Choy

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

R F Devore

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

K R Hande

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

L L Porter

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P Rosenblatt

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

F Yunus

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

L Schlabach

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

C Smith

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Y Shyr

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D H Johnson

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

0 references

publication date

1 July 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

47

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

931-937

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Promotion of microtubule assembly in vitro by taxol

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Taxol binds to polymerized tubulin in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Taxol binds to cellular microtubules

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Investigation of taxol as a potential radiation sensitizer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro studies of Taxol as a radiation sensitizer in human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Taxol in combination with acute and low dose rate irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation and taxol effects on synchronized human cervical carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated fractionation vs hyperfractionation: rationales for several treatments per day.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCL

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatin chemotherapy in patients with unresectable stage III non-small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of Radiation Therapy Oncology Group 90-15

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation therapy oncology group (RTOG) 92-04

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900420-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(00)00420-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10863062%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73915268&oldid=1756325187"